Dr. Bridget Bradley teaches at Pacific University School of Pharmacy and practices as a pharmacist at one of Virginia Garcia Memorial Health Center’s primary care clinics in Hillsboro, Oregon. Learn how Dr. Bradley, as the only psychiatric pharmacist within the health center’s five clinics, is essential to the success of the entire mental health team.
Dr. Dana Chiulli is a psychiatric pharmacist at the Ralph H. Johnson Veterans Affairs (VA) Outpatient Clinic in Savannah, Georgia, a satellite of the VA Hospital in Charleston, South Carolina. Learn how Dr. Chiulli improves access to care for Veterans with a wide variety of locations and needs.
Dr. Jeffrey Gold is a psychiatric pharmacist and the psychiatric pharmacy residency director at the Veterans Affairs (VA) Rocky Mountain Regional Medical Center in Denver, Colorado. Find out how he has become an integral part of the treatment team and extended its reach via telehealth.
Dr. Rosana Steavenson is a psychiatric pharmacist and the program manager of the Mental Health Clinical Pharmacy Program at the South Texas Veterans Affairs (VA) Health Care System. Learn how Dr. Steavenson impacts treatment at her practice site and throughout the country.
This pharmacist toolkit provides clinicians with evidence-based information necessary to safely and confidently manage patients who are candidates for treatment with MAOIs.
This toolkit provides a resource for recognizing, understanding, and managing episodes of agitation and forms of aggression encountered in clinical practice.
AAPP’s resource document on Methamphetamine Use Disorder provides information on screening, diagnosis, intoxication, withdrawal, treatment, co-occurring psychiatric disorders, special populations, and harm reduction strategies.
AAPP's pharmacist toolkit on Xylazine is intended to highlight both the evidence base available as well as strategies of clinical decision making used by expert clinicians.
The existance of the CPNP Foundation is a direct reflection of the selfless dedication of you as CPNP members. Thank you so much to everyone who contributed to our $40,000 year-end fundraising goal! We are thrilled to continue this important, ongoing work. Donate Now and Make Your Pledge for 2020.
Antipsychotic medications are a central part of the treatment process for those with schizophrenia and other mental health conditions, including depression and bipolar disorder. As a result, the potential for an antipsychotic to contribute to the development of a drug induced movement disorder continues to be a clinical concern.
Toolkit on harm reduction provides tips and guideline summaries in the following areas: consequences of injection drug use, harm reduction services, activities, policies, stigma, potential barriers, professional/policy support, resources, and data sources.
The AAPP Residents and New Practitioners Committee is pleased to provide a suggested reading list of the top references as a service and as a forum for member discussion. Consider these resources as a foundation for your reference library.
Toolkit with tips and guideline summaries on opioid use disorder: screening, diagnosis, withdrawal, medications for treatment, overdose prevention education/treatment, special populations, co-occurring disorders, harm reduction strategies, and references.
This free Comprehensive Medication Management (CMM) guide provides webinars introducing CMM and helpful tools for implementing CMM.
This pharmacist toolkit provides quick tips on an overview, HCV medications quick references, drug interactions of Hepatitis C Virus treatments, and references.
This toolkit provides tips and guidance in the following areas of Buprenorphine Initiation: Buprenorphine Treatment, Traditional Buprenorphine Initiation, Low Dose Overlap Initiation, Special Populations, Harm Reduction, Helpful Resources, and References
These free articles are intended to provide advice from experts for students, residents, and new practitioners.
Psychiatric pharmacists are advanced practice clinical pharmacists committed to being part of an interdisciplinary team treating substance use disorders often in combination with serious mental illness. AAPP members have authored numerous substance use disorder toolkits, documents, and educational activities to further the knowledge of pharmacists and other health care professionals.
Dr. Smitha Murthy is an Assistant Professor of Psychiatry at the University of Austin Dell Medical School, clinical faculty on the Consultation-Liaison Psychiatry Service as part of Ascension Seton. She is board-certified in Psychiatry and Consultation-Liaison Psychiatry, and serves as the site director for the Psychiatry C&L service for medical students, residents, and fellows at Seton Medical Center Austin.
AAPP's membership consists of psychiatric pharmacy practitioners, residents, fellows, and students who are dedicated to helping people living with mental health disorders. We share these national and international days as a way to raise awareness of mental health and the role pharmacists can play.
The existance of the CPNP Foundation is a direct reflection of the selfless dedication of you as CPNP members. The CPNP Foundation is seeking to meet its $50,000 year-end fundraising goal to support this important, ongoing work and is asking for your continued support with a generous donation during our year-end fundraising campaign. Your donation will support the following three areas:
Dr. Troy Moore, PharmD, MS, BCPP, discusses how to incorporate research into clinical practice post-residency.
Richard J. Silvia, PharmD, BCPP discusses ways to communicate risks vs benefits of OTCs in patients with anxiety.